|
||||||||||||||||
| HUM-MOLGEN -> Events -> Courses and Workshops | ||||||||||||||||
| IBC's CMC Regulatory Compliance of Biopharmaceuticals | ||||||||||||||||
| April 03, 2003 | ||||||||||||||||
|
-, Courtyard Durham RTP, Durham, NC June 23-24, 2003 With the constant changing landscape of the biopharmaceutical industry, coupled with ongoing changes in the CMC compliance regulations, it has become increasingly important to be able to identify and effectively respond to the CMC issues. At each stage of clinical trial development the basic question will be addressed: 'What do we absolutely have to do from a CMC perspective to be successful in getting our biopharmaceutical through the clinical trials and into the market?' While the focus is on FDA requirements, global CMC issues involving EMEA and ICH are also discussed. |
||||||||||||||||
| Organized by: | IBC Life Sciences | |||||||||||||||
| Invited Speakers: | Course Instructor: John Geigert, Ph.D., RAC President, BioPharmaceutical Quality Solutions |
|||||||||||||||
| Deadline for Abstracts: | - | |||||||||||||||
| Registration: | Phone (508) 616-5550 x1004 Fax (508) 616-5522 Email reg@ibcusa.com Online www.LifeSciencesInfo.com/2891 Mail IBC USA Conferences, Inc. One Research Drive Suite 400A Westborough, MA 01581-5195 | |||||||||||||||
| E-mail: | reg@ibcusa.com | |||||||||||||||
| Posted by: | James G. Prudhomme | |||||||||||||||
| Host: | host-65-124-112-226.ibcusa.com | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||